• Honorary Presidents
• Local authorities

• J. K. Frenkel
  • Proof of the Identity of the New Oocyst and Toxoplasma Infectivity in 1970
• W. de Souza
  • Brazilian contribution for a better knowledge on the biology of Toxoplasma gondii

• A. Mérieux - 100 years of fight

• Elmer Pfefferkorn
• Georges Desmonts
• Jack K. Frenkel
• Jack S. Remington
• Jitender P. Dubey
• Mário Endzfeld Camargo
• Pierre Ambroise-Thomas

Chairpersons: J. K. Frenkel and F. Derouin

• Conference: Toxoplasma gondii from 1908 to 2008 - Homage to Nicolle, Manceaux and Splendore
  • D. Ferguson

• Conference (20 min): Population biology of T. gondii strains. What’s out there and where did they come from?
  • J. P. Dubey
• Conference (20 min): Influence of parasite genotype on clinical manifestations
  • D. Ajzenberg
• Conference (20 min): Human genetic markers and clinical manifestations in humans
  • J. Blackwell

• Conference (20 min): Identifying parasite genes and proteins influencing disease outcome
  • D. Sibley
• Conference (20 min): Introducing proteins into the host cell
  • J. F. Dubremetz
• Conference (20 min): Mechanisms of molecular cross-talk with host cell
  • J. Boothroyd
• Conference (2 x15 min): Regulating gene expression
  • A. Hakimi / K. Kim

• Conference (20 min): Understanding genome organization and microarray analysis of expression and genotype
  • D. Roos
• Conference (20 min): Understanding mechanisms and role of differentiation in pathogenesis
  • W. Sullivan

• Molecular epidemiology
• Gene expression and regulation
• Cell biology

• Role of glycosylphosphatidylinositols in the pathogenicity of apicomplexan parasites
  (N. Azzouz, F. Kamena, B. Lepenies, M. Treeck, T. W. Gilberger, P. H. Seeberger)
• Interaction and cystogenesis of Toxoplasma gondii within the skeletal muscle cells in vitro
  (E.V. Guimarães, L. Carvalho, H.S. Barbosa)
• Serotyping of Toxoplasma gondii: striking homogeneous pattern between symptomatic and asymptomatic infections within Europe and South America
  (F. Peyron, S. Morisset, J. Lobry, J. Garweg, E. Petersen, V. Meroni, J. E. Gomez-Marin, A. de-la-Torre, B. Carme, J. F. Garin, M-F. Cesbron)
• Genetic characterization of Toxoplasma gondii isolates from China
  (P. Zhou, H. Zhang, R.Q. Lin, H.Q. Song, C. Su, X.Q. Zhu)

• How can the influence of strain type be of use clinically?
• What do the clinicians need from the basic scientists and vice versa?
• What data need to be acquired and from what group of patients?
• Does Toxoplasma disseminate through the body inside cells or extracellularly?

Pannellists: M-L. Dardé, D. Sibley, M. Grigg, A. Barragan, C. Carvalheiro and F. Peyron

• Conference (20 min): Immunology of T. gondii infection in the immunocompetent host
  • C. Hunter
• Conference (20 min): NK cells, dendritic cell, mucosal immunity
  • Buzoni-Gatel
• Conference (20 min): Host factors and the gut flora impact outcome of oral infection with Toxoplasma gondii
  • O. Liesenfeld
• Conference (20 min): New developments in vaccines against T. gondii
  • E. Innes
• Conference (20 min): Toxoplasma gondii, CD40 and autophagy
  • C. Subauste

• Conference (20 min): New findings on physiopathology of ocular toxoplasmosis
  • R. Belfort
• Conference (20 min): Treating ocular toxoplasmosis - current evidence
  • M. Stanford

Screening for toxoplasmosis During Pregnancy: a French, Italian and Brazilian Perspective
President: A. W. Ferreira. Speakers: F. Peyron, V. Meroni and E. G. Lago
Chairpersons: R. McLeod and V. Chioccola

• Conference (20 min): Systematic analysis of vesicle trafficking in Apicomplexan parasites
  • M. Meissner
• Conference (20 min): What new metabolism findings could bring to therapeutics?
  • E. Maréchal

• Immunology
• Cell biology
• Metabolism
• New drugs
• Ocular toxoplasmosis

• A GRA1-GRA7 cocktail DNA vaccine primes anti-Toxoplasma immune responses in mice and pigs
  (E. Jongert, V. Melkebeek, S. De Craeye, D. Verhelst, E. Cox)
• Ribosomal protein S13 conditional knockout parasite protects mice from toxoplasmosis
  (R. McLeod, S. Hutson, E. Mui, B. Rohrman, W. Witola, N. von Poppel, R. Schaap)

• Why do attenuated strains provide protection and not subunit and plasmid vaccines?
• What is the role of adjuvants? Should we focus more on adjuvants compared to selecting antigens?
• What is an appropriate endpoint? Reduction in eye symptoms, prevention of transmission freedom of tissue cysts in the immunized host?
• Do we need to test vaccines for protection against different T. gondii genotypes?

• Conference (2 x 15 min): Long term follow-up of children in
  • Europe (F. Peyron) and
  • USA (R. McLeod)
• Conference (15 min): Cohort of congenital toxoplasmosis in South America
  • J. Gomez-Marin
• Conference (20 min): Critical review of treatment efficacy for congenital toxoplasmosis
  • R. Gilbert
• Conference (20 min): Options for clinical trials for treatment of ocular and congenital toxoplasmosis
  • G. Chêne

• Conference (20 min): Oocyst wall formation and composition in coccidian parasites
  • N. Smith
• Video link with Dartmouth Medical School , New Hampshire, USA (10 minutes): “Greetings to Elmer Pfefferkorn
• Conference (10 min): Detection of Toxoplasma gondii in water: proposition of a strategy and evaluation in Champagne-Ardenne region
  • I. Villena
• Conference (10 min): Environmental research on toxoplasmosis: where can it take us?
  • L. Bahia-Oliveira
• Conference (10 min): T. gondii in animal used for human consumption
  • A. Tenter
• Conference (10 min): Risk assessment for food borne toxoplasmosis
  • F. Derouin
• Conference (10 min): Disease burden in DALY’s
  • L. M. Kortbeek

• Diagnosis and treatment
• Environment

• Toxo DB
  • D. Roos
• Biological Resource Center Toxoplasma
  • M-L. Dardé
• Other experiences
  • D. Sibley